<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230821059204N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-10-08</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Duloxetine in knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of adding duloxetine to exercise therapy on pain and function of patients with knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72787</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment, Other design features: The intervention in the first group is the administration of duloxetine (Abidi company) along with exercise therapy. The intervention in the second group is exercise therapy alone, Randomization description: Participants are randomly divided into two groups by numerical random selection process, which are odd numbers for the first group (duloxetine combined with exercise therapy) and even numbers for the second group (exercise therapy).</study_design>
      <phase>3</phase>
      <hc_freetext>Osteoarthritis of knee.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The prescription of Duloxetine (Abidi Company) is 20 mg per day for one week, then 30 mg per day for the next week, and finally 40 mg per day for the continuation of the study, which is done along with exercise therapy. After the end of 12 weeks of therapeutic intervention, in order to reduce the side effects of drug discontinuation, patients enter the drug tapering phase and receive duloxetine 20 mg for one week, and finally the drug is discontinued. Exercise therapy will be knee and hip isometric exercises and hamstring muscle stretching, and then progress to hip flexion and knee extension isotonic exercises in a sitting position with ankle weights at 50-70% of one repetition maximum . Exercise is home-based, where basic training will be given by the doctor in the clinic, and a booklet containing the form and explanation of how to do the exercises will be provided to the patients as a guide for doing the exercises at home. A phone number will also be provided to patients so that they can contact their doctor if they have any questions or problems about taking medicine or exercising. Exercises are for 4 weeks and 5 times a week. Each exercise is performed in three sets with 10 repetitions until exhaustion. Exercises include (1) seated isotonic exercise for the quadriceps, (2) isometric exercise for the quadriceps, (3) supine isotonic exercise for the hip extensors, (4) isometric seated exercise on the chair for the hip adductors, (5) side-lying isotonic exercise for the hip abductors, (6) low-distance squats, and (7) the seated hamstring stretch. Intervention 2: Control group: Exercise therapy will be knee and hip isometric exercises and hamstring muscle stretching, and then progress to hip flexion and knee extension isotonic exercises in a sitting position with ankle weights at 50-70% of one repetition maximum . Exercise is home-based, where basic training will be given by the doctor in the clinic, and a booklet containing the form and explanation of how to do the exercises will be provided to the patients as a guide for doing the exercises at home. A phone number will also be provided to patients so that they can contact their doctor if they have any questions or problems about taking medicine or exercising. Exercises are for 4 weeks and 5 times a week. Each exercise is performed in three sets with 10 repetitions until exhaustion. Exercises include (1) seated isotonic exercise for the quadriceps, (2) isometric exercise for the quadriceps, (3) supine isotonic exercise for the hip extensors, (4) isometric seated exercise on the chair for the hip adductors, (5) side-lying isotonic exercise for the hip abductors, (6) low-distance squats, and (7) the seated hamstring stretch.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hanieh Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Department, Mostafavian Clinic, Razi No. 3 Alley, Razi St.</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816868890</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>H.ahmadi@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hanieh Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Department, Mostafavian Clinic, Razi No. 3 Alley, Razi St.</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816868890</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>H.ahmadi@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 40-80 years
Knee pain more than 14 days per month and the average pain score Visual Analogue score (VAS) ≥ 4 during the 3-month period before the first visit
The grade of knee osteoarthritis is 2 and 3 based on the Kallgren-Lawrence classification
BMI ≤40
The knee should be stable
Good cognitive status
The ability to understand the study protocol and the mental ability to answer the questions of the questionnaires
Willingness to participate in the study</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Deformity of the knee
Spondylolisthesis
Lumbar radiculopathy
Inflammatory arthritis
Autoimmune disorder
Septic arthritis
Any other concomitant disease such as liver and kidney disease
Contraindications for duloxetine (current use of monoamine oxidase inhibitors or poorly controlled angle-closure glaucoma)
Previous exposure to duloxetine
Concomitant use of other drugs that affect the central nervous system (such as benzodiazepines)
History of allergy to duloxetine
Metabolic diseases
Anticoagulation therapy
pregnancy
History of aggressive knee treatments in the last 6 months
Knee joint replacement at any time
Current infection in the affected limb</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The prescription of Duloxetine (Abidi Company) is 20 mg per day for one week, then 30 mg per day for the next week, and finally 40 mg per day for the continuation of the study, which is done along with exercise therapy. After the end of 12 weeks of therapeutic intervention, in order to reduce the side effects of drug discontinuation, patients enter the drug tapering phase and receive duloxetine 20 mg for one week, and finally the drug is discontinued. Exercise therapy will be knee and hip isometric exercises and hamstring muscle stretching, and then progress to hip flexion and knee extension isotonic exercises in a sitting position with ankle weights at 50-70% of one repetition maximum . Exercise is home-based, where basic training will be given by the doctor in the clinic, and a booklet containing the form and explanation of how to do the exercises will be provided to the patients as a guide for doing the exercises at home. A phone number will also be provided to patients so that they can contact their doctor if they have any questions or problems about taking medicine or exercising. Exercises are for 4 weeks and 5 times a week. Each exercise is performed in three sets with 10 repetitions until exhaustion. Exercises include (1) seated isotonic exercise for the quadriceps, (2) isometric exercise for the quadriceps, (3) supine isotonic exercise for the hip extensors, (4) isometric seated exercise on the chair for the hip adductors, (5) side-lying isotonic exercise for the hip abductors, (6) low-distance squats, and (7) the seated hamstring stretch.</i_keyword>
      <i_keyword>Control group: Exercise therapy will be knee and hip isometric exercises and hamstring muscle stretching, and then progress to hip flexion and knee extension isotonic exercises in a sitting position with ankle weights at 50-70% of one repetition maximum . Exercise is home-based, where basic training will be given by the doctor in the clinic, and a booklet containing the form and explanation of how to do the exercises will be provided to the patients as a guide for doing the exercises at home. A phone number will also be provided to patients so that they can contact their doctor if they have any questions or problems about taking medicine or exercising. Exercises are for 4 weeks and 5 times a week. Each exercise is performed in three sets with 10 repetitions until exhaustion. Exercises include (1) seated isotonic exercise for the quadriceps, (2) isometric exercise for the quadriceps, (3) supine isotonic exercise for the hip extensors, (4) isometric seated exercise on the chair for the hip adductors, (5) side-lying isotonic exercise for the hip abductors, (6) low-distance squats, and (7) the seated hamstring stretch.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The patient's pain level is based on the BPI (Brief Pain Inventory) short pain questionnaire, in the range of 0 to 10. Timepoint: At the beginning of the study before the start of the intervention and at the end of the fourth week and then at the end of the study at the end of the 12th week of the intervention. Method of measurement: The patient will be asked about her/his pain level using the BPI (Brief Pain Inventory) short pain questionnaire in the range of 0 to 10.</prim_outcome>
      <prim_outcome>Estimating pain, stiffness and physical activity in patients with knee osteoarthritis using the WOMAC (The Western Ontario and McMaster Universities Arthritis Index) questionnaire. Timepoint: At the beginning of the study before the start of the intervention and at the end of the fourth week and then at the end of the study at the end of the 12th week of the intervention. Method of measurement: The performance of the patient will be measured using the WOMAC (The Western Ontario and McMaster Universities Arthritis Index) questionnaire, the level of the patient's performance will be measured in the range of 0 to 96.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Knee extension strength based on 1-RM (one-repetition maximum). Timepoint: At the beginning of the study before the start of the intervention and at the end of the fourth week and then at the end of the study at the end of the 12th week of the intervention. Method of measurement: Using the knee extension machine, we obtain the maximum weight that a person can lift in the range of 4 to 10 repetitions, then by the formula one-repetition maximum = weight/1- (0.02*repetition) the amount of one-repetition maximum; where weight is the amount of the last weight that the person was able to lift and repetition is the number of repetitions of the lifted weight.</sec_outcome>
      <sec_outcome>Evaluation of patients' functional mobility during daily activities using the Timed Up and Go (TUG) test. Timepoint: At the beginning of the study before the start of the intervention and at the end of the fourth week and then at the end of the study at the end of the 12th week of the intervention. Method of measurement: In the Timed Up and Go test, after familiarizing the person with how to do it, the patient first gets up from a standard chair (the chair does not have handles and the height from the seat of the chair to the floor is 50 cm), then walks 3 meters, then turns and goes back to the chair with the same speed as usual and sits on the chair. The time spent for this movement sequence will be recorded in seconds using a stopwatch. The best time will be recorded after three times of testing.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-19</approval_date>
        <contact_name>Ethics Committee of Mazandaran University of Medical Sciences, Imam Hospital</contact_name>
        <contact_address>Serah Joibar, the beginning of Vali Asr Highway, the headquarters of Mazandaran University of Medical Sciences and Health Services sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
